StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.63−0.16 (-4.22%)

Close on Nov 16, 2026Market cap $198.49MP/E –Yield –

Intercure EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Intercure's EV/EBITDA was 27.3× on Feb 29, 2024, against 49.2× a year earlier. Over the last 2 years it ranged from 15.0× to 119.3×, with a median of 49.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Feb 29, 202427.3×+10.1
2023Dec 29, 202317.2×−43.0
2022Dec 30, 202260.3×–

More Intercure figures

See a number that looks wrong?